Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

28
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
28
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

26
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
26

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Genetic drivers of etiologic heterogeneity in thyroid cancer.

Nature communications·2026
Same author

Cross-definition GWAS of IBS in 2.8 million individuals reveals cardiometabolic and triglyceride-linked mechanisms.

Gut·2026
Same author

Telomere maintaining germline and somatic variants in thyroid cancer and melanoma.

medRxiv : the preprint server for health sciences·2026
Same author

The Biobank Rare Variant consortium powers the discovery of rare genetic associations through global collaboration.

medRxiv : the preprint server for health sciences·2026
Same author

Clinical validation of an artificial intelligence model for thyroid fine-needle aspiration biopsy indication: comparison with TI-RADS systems and human specialists in a Chilean public hospital.

Frontiers in endocrinology·2026
Same author

Combined intracranial hemorrhage subtypes should not change modified Brain Injury Guidelines criteria.

The journal of trauma and acute care surgery·2026

相关实验视频

Updated: Apr 30, 2026

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

483

针对持续性或复发性分化甲状腺癌的多次淋巴结解剖后的长期结果.

Martin Jose Barrio1, Nikita Pozdeyev2, Robert C McIntyre1

  • 1Division of GI, Trauma, and Endocrine Surgery, Department of Surgery, University of Colorado School of Medicine, 12631 E 17th Ave., C-313 Mail Stop, Aurora, CO, 80045, United States.

American journal of surgery
|November 3, 2024
PubMed
概括

重复的淋巴结解剖是复发性差异化甲状腺癌 (DTC) 的关键. 虽然有效,但每次手术的成功率都会下降,并发症风险会增加,特别是在中央部剖析期间.

关键词:
子解剖 子解剖 子解剖 子解剖对治疗的反应.甲状腺癌是什么?甲状腺癌是什么?

更多相关视频

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
05:12

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Published on: May 12, 2023

3.6K
Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma
04:01

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma

Published on: September 15, 2023

730

相关实验视频

Last Updated: Apr 30, 2026

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

483
Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
05:12

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Published on: May 12, 2023

3.6K
Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma
04:01

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma

Published on: September 15, 2023

730

科学领域:

  • 在瘤学瘤学.
  • 手术瘤学手术瘤学
  • 内分泌学 在内分泌学.

背景情况:

  • 局域性复发性/持久性差异化甲状腺癌 (DTC) 通常需要重复的淋巴结剖析.
  • 关于多次手术对DTC复发的安全性和长期疗效的数据有限.

研究的目的:

  • 评估重复淋巴结解剖的安全性和有效性,用于局部区域的复发性/持久性DTC.
  • 评估多次手术对治疗反应和并发症率的影响.

主要方法:

  • 在1998年至2022年间接受了宫淋巴结解剖的患者的回顾性分析.
  • 数据收集包括人口统计,最初的甲状腺手术细节,随后的淋巴结剖析,随访和治疗反应.

主要成果:

  • 随着连续的重复手术,优异反应率下降:一次手术后35.7%,两次手术后20.3%,三次手术后12%,四次重复手术后0%.
  • 优秀反应的累积率为41.7%.
  • 永久性缺甲状腺症或喉神经复发性损伤的总体风险为5.1%,在接受重复手术中心部剖析 (CNDx) 的患者中,与没有先前CNDx (2.5%) 的患者相比,患者的发病率更高 (8.7%).

结论:

  • 手术是复发性/持久性DTC的主要治疗方法,但随着手术的增加,疗效会下降.
  • 永久性并发症的风险很低,但在重复的中央部剖析 (CNDx) 时会增加.